Century Therapeutics, Inc.
Ticker: 1850119
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2025 | Q1 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 | Q2 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 109.16+0.0% | 109.16+0.0% | 109.16+13717.7% | 0.79+2.6% | 0.77-10.5% | 0.86+473.3% | 0.15+50.0% | 0.10 |
| Total Income | 109.16+0.0% | 109.16+0.0% | 109.16+13717.7% | 0.79+2.6% | 0.77-10.5% | 0.86+473.3% | 0.15+50.0% | 0.10 |
| EXPENSES | ||||||||
| Expenditure | 32.60-6.8% | 34.99+7.3% | 32.60-8.4% | 35.58+0.1% | 35.53+10.5% | 32.16-10.1% | 35.77+1.7% | 35.18 |
| Tax | — | — | — | -0.01-150.0% | 0.02 | 0.00-100.0% | 0.59-37.9% | 0.95 |
| PROFIT | ||||||||
| PBT | — | 76.56 | — | -31.23-0.1% | -31.19-11.2% | -28.06+12.7% | -32.13+0.6% | -32.34 |
| Net Profit | 76.56+0.0% | 76.56+0.0% | 76.56+345.1% | -31.23-0.1% | -31.21-11.2% | -28.06+14.2% | -32.72+1.7% | -33.29 |
| KEY METRICS | ||||||||
| OPM % | — | 67.95% | — | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | 70.13% | 70.13% | 70.13%+170.13pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | — | 0.89 | — | -0.37+2.6% | -0.38+15.6% | -0.45+18.2% | -0.55+1.8% | -0.56 |
Corporate Events
Board MeetingIPSC
202615Jun
Board Meeting
Chief Scientific Officer Chad Cowan's employment terms amend…
SEC Filing ↗ Board MeetingIPSC
202611Jun
Board Meeting
The 2026 Annual Meeting of Stockholders addressed the electi…
SEC Filing ↗